Literature DB >> 27785192

An Acute Abdominal Catastrophe in a HIV Positive Patient.

Vinaya Gaduputi1, Harish Patel1, Vamshidhar Vootla1, Usman Khan1, Sridhar Chilimuri1.   

Abstract

We report this case of a 45-year-old man with HIV-AIDS on HAART therapy who presented with acute abdominal pain and renal failure. He was found to have pneumatosis intestinalis on computerized axial tomography scan of the abdomen. He underwent emergent explorative laparotomy, which revealed a necrotic large bowel segment for which a right-sided hemicolectomy and ileostomy were performed. The patient subsequently developed septic shock and hypoxic respiratory failure. He expired a week after the surgical procedure. Acute abdominal events due to vascular catastrophes secondary to hypercoagulability, endothelial dysfunction and accelerated atherosclerosis have been reported in HIV positive patients.

Entities:  

Keywords:  Acute abdomen; HIV

Year:  2012        PMID: 27785192      PMCID: PMC5051126          DOI: 10.4021/gr451w

Source DB:  PubMed          Journal:  Gastroenterology Res        ISSN: 1918-2805


Introduction

Longevity of the patients infected with HIV has increased since the introduction of Highly Active Antiretroviral Therapy (HAART). However, many patients on HAART therapy develop long-term metabolic derangements such as dyslipidemia, diabetes mellitus and insulin resistance [1-3]. HAART therapy and HIV infection in itself, produce chronic inflammation and cellular homeostatic stress response cascade [4] .It has been postulated that the increased cardiovascular risk is the result of HIV induced direct viral injury, endothelial dysfunction, hypercoagulabilty [5, 6]; opportunistic infections induced vaso-occlusive disease (especially CMV) [7] or chronic inflammatory state [8]. HIV induced large-vessel related catastrophes have been reported in the literature, including acute abdomen resulting from intestinal ischemia. The review of literature has shown this to happen usually as a result of atherogenic lipid profile (induced by HIV, HAART therapy or both) [9] or direct vaso-occlusive effect of opportunistic infections such as CMV. We postulate that subclinical atherosclerosis (as observed in Carotid and Coronary Intima media thickening (IMT) measurement studies [10] of the mesenteric arterial tree with superimposed hypercoagulabilty has a potential to produce critical ischemia, in presence of a precipitating cause such as renal failure or sepsis. We present one such unusual presentation of mesenteric ischemia probably secondary to such atherosclerosis.

Case Report

A 56-year-old Hispanic man with HIV-AIDS, hypertension and deep vein thrombosis (DVT) on Warfarin presented to the Emergency Room with severe midline low back pain and right sided flank pain. Physical examination revealed stable vital signs, oral thrush and unremarkable cardiopulmonary, abdominal examination. The computerized axial tomography (CAT) scan of the abdomen revealed no acute intra-abdominal pathology. However, CAT scan revealed osteoporosis with central endplate depression of L5 vertebra. Magnetic Resonance Imaging (MRI) of the lumbosacral spine failed to reveal any acute pathology but did show degenerative changes, bridging osteophytes. The patient was treated for musculoskeletal pain with opiate analgesics and oral thrush with Fluconazole, while continuing the HAART therapy. Subsequently, patient developed acute renal failure on the third day of hospitalization (serum creatinine increased from 1.3 mg/dL to 2 mg/dL) which worsened further acutely over the course of the next 24 hours (serum creatinine increased from 2 mg/dL to 7.9 mg/dL) with development of severe hyperkalemia (6.4). Patient’s HAART therapy and other nephrotoxic medications (Lisinopril, Allopurinol) were held. On the fourth day of hospitalization, patient developed diffuse abdominal pain and worsening constipation. A Computerized Tomogram of the abdomen revealed signs of bowel obstruction, pneumatosis intestinalis and free air in the mesenteric and portal venous systems (Fig. 1-3). The patient underwent emergent explorative laparotomy that revealed necrotic bowel that required right-sided hemicolectomy and ileostomy. Patient subsequently developed septic shock and died on the thirteenth day of hospitalization.
Figure 1

Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (black arrow) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis.

Figure 2

Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (white arrows) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis.

Figure 3

Transverse Section of a non-contrast CAT scan of abdomen showing the air bubble in the portal vein.

Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (black arrow) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis. Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (white arrows) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis. Transverse Section of a non-contrast CAT scan of abdomen showing the air bubble in the portal vein.

Discussion

We present a middle-aged man with history of HIV-AIDS who presented with an acute mesenteric ischemia. Differential diagnoses of such presentation include: 1) mesenteric ischemia from an acute thrombotic event; 2) mesenteric ischemia resulting from vasocclusive opportunistic infections such as CMV; 3) mesenteric ischemia from an atheroembolic event; 4) an undiagnosed thrombophilia; 5) Non-occlusive mesenteric ischemia (NOMI) and 6) subclinical atherosclerosis with superimposed acute systemic insults such as renal failure and sepsis. Mesenteric ischemia from an acute thrombotic event as result of hypercoagulabilty is possible in HIV positive patients. Patient already had an episode of venous thrombosis in the past and was on an anticoagulation medication. The patient at the time of presentation was adequately anticoagulated. Mesenteric ischemia from an acute thrombotic event or an undiagnosed thrombophilia being the cause of this presentation is extremely unlikely in the setting of supra-therapeutic INR (5.5) of the patient. Opportunistic infections such as CMV would also have been unlikely, as patient’s CD4 T-helper cells count was above 150. Though Protease Inhibitors are notorious for causing lipid panel anomalies and endothelial dysfunction [4], an atheroembolic cause is not probable in the setting of patient’s near normal lipid panel. A more direct evidence of this came from surgical pathology where the mesenteric vessels were found to be atherosclerotic but did not reveal any occlusive atheroma or thrombus. Also, there were no other evidences of metabolic syndrome or lipodystrophy seen with chronic protease inhibitor therapy. Nonocclusive mesenteric ischemia often presents with watershed zone ischemia. However, it is usually associated with hypovolemia, episodes of hypotension and precipitating drugs such as diuretics or vasoconstrictors, none of which were present in this patient [11]. However, NOMI has been found to be often associated with renal failure, such as found in this patient. Subclinical atherosclerosis produced by direct viral injury or metabolic effects of the HAART, superimposed by acute splanchnic vasoconstriction in response to acute renal failure and sepsis could have produced the clinical scenario as seen in this patient. Given the fact that he had acute renal failure, which is associated with NOMI and was on HAART therapy for HIV, which is known to be atherogenic as demonstrated by his atherosclerotic mesenteric vessels, mesenteric ischemia might have resulted from a combination of both the etiologies. With increasing use of HAART medications and increasing prevalence of resultant metabolic derangements, mesenteric ischemia should be seriously considered in patients presenting with acute abdomen.
  11 in total

1.  Independent predictors of metabolic syndrome in HIV-infected patients.

Authors:  Paulo R Alencastro; Sandra C Fuchs; Fernando H Wolff; Maria Letícia Ikeda; Ajácio B M Brandão; Nemora T Barcellos
Journal:  AIDS Patient Care STDS       Date:  2011-09-21       Impact factor: 5.078

2.  Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.

Authors:  Faroudy Boufassa; Cécile Goujard; Jean-Paul Viard; Robert Carlier; Bénédicte Lefebvre; Patrick Yeni; Olivier Bouchaud; Jacqueline Capeau; Laurence Meyer; Corinne Vigouroux
Journal:  Antivir Ther       Date:  2012

Review 3.  [HIV infection, antiretroviral therapy, and endothelium].

Authors:  David Hürlimann; Rainer Weber; Frank Enseleit; Thomas F Lüscher
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

Review 4.  Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.

Authors:  Absalon D Gutierrez; Ashok Balasubramanyam
Journal:  Endocrine       Date:  2011-12-02       Impact factor: 3.633

5.  Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients.

Authors:  R Mulder; Y I G V Tichelaar; H G Sprenger; A B Mulder; W M Lijfering
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

6.  Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

Authors:  Laura W Musselwhite; Virginia Sheikh; Thomas D Norton; Adam Rupert; Brian O Porter; Scott R Penzak; Jeff Skinner; JoAnn M Mican; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2011-03-27       Impact factor: 4.177

Review 7.  Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection.

Authors:  Katie L Kiser; Melissa E Badowski
Journal:  Pharmacotherapy       Date:  2010-12       Impact factor: 4.705

8.  HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.

Authors:  Daniela Francisci; Silvia Giannini; Franco Baldelli; Mario Leone; Barbara Belfiori; Giuseppe Guglielmini; Lisa Malincarne; Paolo Gresele
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

Review 9.  Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.

Authors:  F De Lorenzo; S Collot-Teixeira; M Boffito; M Feher; B Gazzard; J L McGregor
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients.

Authors:  A Tabib; C Leroux; J F Mornex; R Loire
Journal:  Coron Artery Dis       Date:  2000-02       Impact factor: 1.439

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.